Interpretation depends on the mass’s position, mobility, morphology, contrast filling, and tissue characteristics rather than on a single visual feature. A lesion attached in a particular cardiac location or moving with blood flow may carry different implications from a fixed structure. Assessing these attributes systematically supports more reliable characterization.
Transthoracic echocardiography, transesophageal echocardiography, cardiac CT, and cardiac MRI contribute different imaging views of a suspected intracardiac mass. The evaluation uses these modalities to examine anatomy, motion, contrast behavior, and tissue properties. Considering the findings together can help separate thrombus from tumor, vegetation, or normal anatomy.
Thrombus, tumor, vegetation, and normal anatomical structures can appear as masses but lead to different clinical interpretations. Correct characterization therefore affects risk assessment and the next management discussion. In particular, identifying a finding as compatible with thrombus can support decisions about anticoagulation and whether imaging follow-up is needed.
The process begins with clinical findings that raise concern, followed by targeted cardiac imaging. Echocardiography, cardiac CT, or cardiac MRI can then be used to examine the suspected mass’s location, mobility, morphology, contrast filling, and tissue characteristics. The resulting characterization guides assessment rather than relying on a single feature.
Location and mobility help describe how the mass relates to cardiac structures, while morphology, contrast filling, and tissue characteristics add information about its nature. Together, these observations support clinical decisions such as anticoagulation, procedural planning, and selection of follow-up imaging. Their value lies in connecting image characterization with a specific management question.
Follow-up imaging can show whether a cardiac thrombus resolves or persists over time. That comparison gives clinicians an objective way to reassess the previously characterized finding and its ongoing significance. It also complements management decisions by showing whether the imaging appearance has changed after the initial evaluation rather than treating the first study as final.